JPRN-UMIN000005250
Completed
未知
Efficacy of ezetimibe for the treatment of non-alcoholic fatty liver disease: A randomized, controlled trial - Efficacy of ezetimibe for the treatment of non-alcoholic fatty liver disease: A randomized, controlled trial
Eishiro Mizukoshi0 sites80 target enrollmentStarted: March 14, 2011Last updated:
Conditionsnon-alcoholic fatty liver disease
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- Eishiro Mizukoshi
- Enrollment
- 80
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients will be excluded from the study if they meet any of the following criteria: 1\)hepatic virus infections (hepatitis B and C) 2\)the current or past consumption of more than 20 g of alcohol daily 3\)concurrent hepatocellular carcinoma, as determined by diagnostic imaging results 4\) hepatic encephalopathy 5\) active infections 6\) severe complication 7\) Woman who has possibility of pregnancy or pregnancy or while suckling. 8\)Case to whom medicine in which it is using together taboo of ezetimibe and describes attention of using together is administered 9\) those who are inadequate for this study as assessed by the investigators
Investigators
Similar Trials
Completed
Not Applicable
Efficacy of Ezetimibe for the patients with Non-alcoholic fatty liver disease (NAFLD)JPRN-UMIN000001071Osaka City University Graduate School of Medicine60
Completed
Phase 2
Ezetimibe Versus Placebo in the Treatment of Non-alcoholic SteatohepatitisNon Alcoholic SteatohepatitisNCT01766713University of California, San Diego50
Completed
Phase 3
Therapeutic fficacy of ezetimibe in patients with nonalcoholic steatohepatitis (NASH): a pilot study.onalcoholic steatohepatitis (NASH)JPRN-UMIN000001258Division of Gastroenterology, Yokohama City University Hospital10
Completed
Not Applicable
A study on efficacy of Ezetimibe in patients with Dyslipidemia associated with Digestive disease-Its effect on biliary bigly metabolismhypercholesterolemiaJPRN-UMIN000004183Hiroshima University hospital Department of General Medicine60
Recruiting
Not Applicable
Effects of ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease; randomized comparison of LDL-cholesterol targeting <70 versus <55mg/dL; Ez-PAVE trialDiseases of the circulatory systemKCT0005547Yonsei University Health System, Severance Hospital3,048